Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Vericel (VCEL) Research & Development: 2010-2025

Historic Research & Development for Vericel (VCEL) over the last 15 years, with Sep 2025 value amounting to $6.3 million.

  • Vericel's Research & Development rose 3.69% to $6.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $25.2 million, marking a year-over-year increase of 1.85%. This contributed to the annual value of $24.8 million for FY2024, which is 17.85% up from last year.
  • Vericel's Research & Development amounted to $6.3 million in Q3 2025, which was down 6.14% from $6.7 million recorded in Q2 2025.
  • Over the past 5 years, Vericel's Research & Development peaked at $7.4 million during Q2 2024, and registered a low of $3.6 million during Q1 2021.
  • Its 3-year average for Research & Development is $6.0 million, with a median of $6.1 million in 2024.
  • In the last 5 years, Vericel's Research & Development soared by 47.06% in 2021 and then fell by 8.58% in 2025.
  • Vericel's Research & Development (Quarterly) stood at $3.9 million in 2021, then surged by 33.66% to $5.2 million in 2022, then dropped by 6.56% to $4.9 million in 2023, then grew by 0.45% to $4.9 million in 2024, then rose by 3.69% to $6.3 million in 2025.
  • Its Research & Development was $6.3 million in Q3 2025, compared to $6.7 million in Q2 2025 and $7.3 million in Q1 2025.